Moallemi S - Search Results

1

Recent advances in various bio-applications of bacteria-derived outer membrane vesicles.

Sadeghi L, Mohit E, Moallemi S, Ahmadi FM, Bolhassani A. Sadeghi L, et al. Among authors: moallemi s. Microb Pathog. 2023 Dec;185:106440. doi: 10.1016/j.micpath.2023.106440. Epub 2023 Nov 4. Microb Pathog. 2023. PMID: 37931826 Review.

2

HIV Drug Resistance and Phylogeny Profile in Naïve and Antiretroviral-Experienced Patients in Tehran, Iran.

Farrokhi M, Moallemi S, Baesi K, Ahsani-Nasab S, Gholami M, Sadeghi L, Mohraz M. Farrokhi M, et al. Among authors: moallemi s. Intervirology. 2016;59(3):131-136. doi: 10.1159/000452712. Epub 2016 Dec 15. Intervirology. 2016. PMID: 27974715 Free article.

3

Different Degrees of Immune Recovery Using Antiretroviral Regimens with Vonavir or Zidovudine/Lamivudine/Efavirenz in HIVPositive Patients Receiving First Line Treatment in Iran.

Sadeghi L, Moallemi S, Tabatabai RA, Esmaeilzadeh A, Ahsani-Nasab S, Ahmadi NE, Bayanolhagh S, Lolaie M, Narouei A, SeyedAlinaghi S, Mohraz M. Sadeghi L, et al. Among authors: moallemi s. Infect Disord Drug Targets. 2018;18(3):207-213. doi: 10.2174/1871526518666180108104031. Infect Disord Drug Targets. 2018. PMID: 29308748

4

There is no Difference Between Sequences of HIV-1 Infected Patients with Stable Clinical Status and HIV-1 Reference Sequence.

Nili M, Tayeri K, Gholami M, Moallemi S, Sabahi F, Kalhori S, Baesi K, Hasibi M. Nili M, et al. Among authors: moallemi s. Infect Disord Drug Targets. 2019;19(1):67-72. doi: 10.2174/1871526518666180222111611. Infect Disord Drug Targets. 2019. PMID: 29473526

5

Antiretroviral Drug Resistance Mutations among HIV Treatment Failure Patients in Tehran, Iran.

Farrokhi M, Moallemi S, Shirkoohi R, Golmohammadi R, Ahsani-Nasab S, Sardashti S, Abbasian L, Baesi K, Mohraz M. Farrokhi M, et al. Among authors: moallemi s. Iran J Public Health. 2017 Sep;46(9):1256-1264. Iran J Public Health. 2017. PMID: 29026792 Free PMC article.

6

[Evaluation of miR-122 level in the plasma of chronically HCV infected patients].

Gholami M, Ravanshad M, Alavian SM, Baesi K, Moallemi S. Gholami M, et al. Among authors: moallemi s. Mol Biol (Mosk). 2016 Mar-Apr;50(2):279-83. doi: 10.7868/S0026898416020075. Mol Biol (Mosk). 2016. PMID: 27239848 Free article. Russian.

7

Early biomarkers for prediction of severe manifestations of dengue fever: a systematic review and a meta-analysis.

Moallemi S, Lloyd AR, Rodrigo C. Moallemi S, et al. Sci Rep. 2023 Oct 14;13(1):17485. doi: 10.1038/s41598-023-44559-9. Sci Rep. 2023. PMID: 37838744 Free PMC article.

8

Diagnostic Value of Erythrocyte Sedimentation Rate and C Reactive Protein in detecting Diabetic Foot Osteomyelitis; a Cross-sectional Study.

Moallemi SK, Niroomand M, Tadayon N, Forouzanfar MM, Fatemi A. Moallemi SK, et al. Arch Acad Emerg Med. 2020 Sep 8;8(1):e71. eCollection 2020. Arch Acad Emerg Med. 2020. PMID: 33134967 Free PMC article.

9

Subtype classification of Iranian HIV-1 sequences registered in the HIV databases, 2006-2013.

Baesi K, Moallemi S, Farrokhi M, Alinaghi SA, Truong HM. Baesi K, et al. Among authors: moallemi s. PLoS One. 2014 Sep 4;9(9):e105098. doi: 10.1371/journal.pone.0105098. eCollection 2014. PLoS One. 2014. PMID: 25188443 Free PMC article.

10

Spiritual intelligence and high risk behaviors.

Moallemi S. Moallemi S. Int J High Risk Behav Addict. 2014 Feb 15;3(1):e18477. doi: 10.5812/ijhrba.18477. eCollection 2014 Mar. Int J High Risk Behav Addict. 2014. PMID: 24971302 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page